Unlocking the Power of the Genome
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
Illumina | Sequencing and array solutions to fuel genomic discoveries
Entity | Type | Tweets | Articles | |
---|---|---|---|---|
![]() | Front Line Genomics Media Production | Other 6 Nov 2023 | | |
![]() | HudsonAlpha Institute for Biotechnology Biotechnology Research, healthtech, biotech, deeptech | Other 2 Mar 2019 | | |
![]() | Genomics England Biotechnology Research | Other 13 Mar 2019 | | |
![]() | UK Biobank Research Services, healthtech, deeptech | Other 30 Oct 2024 | | |
![]() | Global Genes Non-profit Organizations, healthtech, deeptech | Other 18 Oct 2018 | | |
![]() | GenomeWeb Book and Periodical Publishing, biotech, deeptech | Other 14 Jun 2019 | | |
![]() | Tohoku University Research Services, edtech | Other 14 Oct 2017 | | |
![]() | CNBC Broadcast Media Production and Distribution | Other 2 May 2018 | | |
![]() | Columbia University Irving Medical Center Hospitals and Health Care, healthtech | Other 15 Nov 2017 | | |
![]() | Cell Press Book and Periodical Publishing, biotech, deeptech | Other 6 Jun 2019 | |